A5044089847- Decision-Making and Behavioral Economics
- Behavioral Health and Interventions
- Behavioral and Psychological Studies
- Autism Spectrum Disorder Research
- Gambling Behavior and Treatments
- Neural and Behavioral Psychology Studies
- Health Systems, Economic Evaluations, Quality of Life
- Substance Abuse Treatment and Outcomes
- Multiple Sclerosis Research Studies
- Attention Deficit Hyperactivity Disorder
- Eating Disorders and Behaviors
- Statistical Methods in Clinical Trials
- Neurotransmitter Receptor Influence on Behavior
- Obsessive-Compulsive Spectrum Disorders
- Cancer-related cognitive impairment studies
- Psychological Well-being and Life Satisfaction
- Psychology of Moral and Emotional Judgment
- Adolescent Sexual and Reproductive Health
- Animal Nutrition and Physiology
- Glioma Diagnosis and Treatment
- Mental Health Research Topics
- Sleep and Wakefulness Research
- Psychology of Social Influence
- Cannabis and Cannabinoid Research
- Brain Metastases and Treatment
University of Kansas
2015-2025
University of Missouri–Kansas City
2022-2023
West Virginia University
2010-2020
Virginia Tech
2011-2014
Lawrence University
2014
Carilion Clinic
2011-2012
University of Maryland, Baltimore County
2008-2009
Kennedy Krieger Institute
2008-2009
Pennsylvania State University
1994
Although humans do not always respond rationally, decades of behavioral economic research have brought order to these irrational patterns responding, particularly in individuals whose maladaptive behavior and the neurobiological dysregulation that presumably undergirds it directly impact their health (drug addiction obesity). These findings given rise a new paradigm, reinforcer pathologies. Specifically, poor decisions are consistently related an inability value future overvaluation specific...
Those who discount the subjective value of delayed rewards less steeply are more likely to engage in physical activity. There is limited research, however, showing whether activity can change rates delay discounting. In a two-experiment series, treatment and maintenance effects novel, effort-paced intervention on discounting were evaluated with multiple baseline designs. Using lap-based method, participants instructed exercise at individualized high low effort levels track their own...
Nearly 50 % of patients with chronic medical illness exhibit poor treatment adherence. When making decisions, these must balance the probability current side effects against long-term benefits. This study examines if behavioral economic construct discounting can be used to explain decisions in disease. Thirty-eight nonadherent and 39 adherent multiple sclerosis (MS) completed a series hypothetical scenarios varied risk benefit probabilities. As described by hyperbolic model, all reported...
Although the effectiveness and risks of multiple sclerosis (MS) therapies are established, relatively little is known about how these benefits perceived weighed by patients. This risk-benefit trade-off important for clinicians, industry, regulators to consider when determining which develop, approve clinical use, recommend individual The primary objective present study was describe differences in MS patients weigh making treatment decisions.Two hundred ninety with completed tasks assessing...
Although effective disease-modifying treatments (DMTs) are available for individuals suffering from multiple sclerosis (MS), many patients fail to take their recommended medications. Unlike medications that provide immediate relief existing symptoms, DMTs decrease the probability of future symptoms (i.e., a probabilistic benefit) while concurrently carrying an appreciable risk side effects cost). Prior research has shown both reducing disease progression and experiencing impact patients'...
The current study developed and tested a multiple-stimulus-without-replacement (MSWO) assessment for potential sexual partners use in research on human immunodeficiency virus. College students (N = 41) first completed an MSWO then hypothetical purchase task encounters with identified by the as high, median, low preference. Overall, responding was consistent that from MSWO, highest valuation observed high-preference partner lowest low-preference partner. Potentially interesting individual...
Multiple sclerosis (MS) is an autoimmune disease that causes a range of problematic symptoms. These symptoms tend to get worse over time, causing substantial impairment in patient quality life. Although many effective disease-modifying therapies (DMTs) exist slow the course MS, patients often do not choose take them, which may be because these medications carry risks side effects, varying from mild severe, while only decreasing probability future In current study, we examined MS patients'...
Chemotherapy-induced cognitive impairment, known also as "chemobrain", is a medical complication of cancer treatment that characterized by general decline in cognition affecting visual and verbal memory, attention, complex problem solving skills, motor function. It estimated one-third patients who undergo chemotherapy will experience impairment. Alterations the release uptake dopamine serotonin, central nervous system neurotransmitters play important roles cognition, could potentially...